Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:12 AM
Study NCT ID:
NCT01203020
Status:
COMPLETED
Last Update Posted:
2023-07-13
First Post:
2010-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation
Sponsor:
West Virginia University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-27
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-13
First Submit QC Date:
None
Study First Post Date:
2010-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-06-21
Results First Submit QC Date:
None
Results First Post Date:
2023-07-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-21
Last Update Post Date:
2023-07-13
Last Update Post Date Type:
ACTUAL